Table 4. Severity distribution of significant co-occurring clinical symptoms.
Male (N = 33) | Female (N = 29) | |
N (%) | N (%) | |
BAI: clinically significant (score≥8) | 21 (63.6%) | 21 (72.4%) |
Mild anxiety (8–15) | 8 (24.2%) | 7 (24.1%) |
Moderate anxiety (16–25) | 11 (33.3%) | 9 (31%) |
Severe anxiety (26–63) | 2 (6%) | 5 (17.2%) |
BDI: clinically significant (score≥10) | 18 (54.5%) | 20 (69%) |
Mild depression (10–18) | 11 (33.3%) | 10 (34.5%) |
Moderate depression (19–29) | 4 (12.1%) | 8 (27.6%) |
Severe depression (30–63) | 3 (9.1%) | 2 (6.9%) |
OCI-R: compatible to OCD severity (score≥21) | 24 (72.7%) | 20 (69%) |
BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; OCI-R: Obsessive-Compulsive Inventory-Revised; OCD: obsessive-compulsive disorder.